| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 1.40e-07 | 739 | 32 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 5.42e-05 | 46 | 32 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 8.89e-05 | 9 | 32 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.07e-03 | 1356 | 32 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.34e-03 | 303 | 32 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.05e-03 | 1160 | 32 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.04e-03 | 1244 | 32 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 3.26e-03 | 53 | 32 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.33e-03 | 188 | 32 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.43e-03 | 1271 | 32 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 4.02e-03 | 59 | 32 | 2 | GO:0001222 | |
| GeneOntologyCellularComponent | chromatin | ZFHX2 POU3F1 POU3F3 ELK1 DLX2 ARID1B SFPQ SUZ12 LEF1 STAG2 PHC1 | 4.86e-06 | 1480 | 31 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | sex chromatin | 4.45e-05 | 7 | 31 | 2 | GO:0001739 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.64e-04 | 13 | 31 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | collagen trimer | 2.98e-04 | 88 | 31 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.99e-04 | 1377 | 31 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | sex chromosome | 1.94e-03 | 44 | 31 | 2 | GO:0000803 | |
| GeneOntologyCellularComponent | PcG protein complex | 2.69e-03 | 52 | 31 | 2 | GO:0031519 | |
| MousePheno | abnormal incus short process morphology | 3.85e-05 | 5 | 28 | 2 | MP:0030394 | |
| Domain | TF_POU_3 | 1.70e-05 | 4 | 32 | 2 | IPR016362 | |
| Domain | Homeobox_CS | 2.75e-04 | 186 | 32 | 4 | IPR017970 | |
| Domain | POU | 3.36e-04 | 16 | 32 | 2 | SM00352 | |
| Domain | POU_2 | 3.36e-04 | 16 | 32 | 2 | PS00465 | |
| Domain | Pou | 3.36e-04 | 16 | 32 | 2 | PF00157 | |
| Domain | POU_dom | 3.36e-04 | 16 | 32 | 2 | IPR000327 | |
| Domain | POU_3 | 3.36e-04 | 16 | 32 | 2 | PS51179 | |
| Domain | POU_1 | 3.36e-04 | 16 | 32 | 2 | PS00035 | |
| Domain | POU | 3.81e-04 | 17 | 32 | 2 | IPR013847 | |
| Domain | Collagen | 4.10e-04 | 85 | 32 | 3 | PF01391 | |
| Domain | Collagen | 4.10e-04 | 85 | 32 | 3 | IPR008160 | |
| Domain | RRM_1 | 4.21e-04 | 208 | 32 | 4 | PF00076 | |
| Domain | RRM | 4.94e-04 | 217 | 32 | 4 | SM00360 | |
| Domain | RRM_dom | 5.85e-04 | 227 | 32 | 4 | IPR000504 | |
| Domain | RRM | 6.15e-04 | 230 | 32 | 4 | PS50102 | |
| Domain | Homeobox | 6.56e-04 | 234 | 32 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.77e-04 | 236 | 32 | 4 | PS00027 | |
| Domain | HOX | 6.88e-04 | 237 | 32 | 4 | SM00389 | |
| Domain | Homeobox_dom | 7.10e-04 | 239 | 32 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 7.10e-04 | 239 | 32 | 4 | PS50071 | |
| Domain | - | 7.67e-04 | 244 | 32 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 9.44e-04 | 258 | 32 | 4 | IPR012677 | |
| Domain | - | 9.72e-04 | 27 | 32 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 1.12e-03 | 29 | 32 | 2 | IPR010982 | |
| Domain | - | 1.33e-03 | 283 | 32 | 4 | 1.10.10.60 | |
| Domain | Homeodomain-like | 2.38e-03 | 332 | 32 | 4 | IPR009057 | |
| Domain | ARM-like | 1.09e-02 | 270 | 32 | 3 | IPR011989 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.88e-05 | 41 | 23 | 3 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.81e-05 | 44 | 23 | 3 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.43e-05 | 53 | 23 | 3 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.28e-04 | 61 | 23 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.48e-04 | 64 | 23 | 3 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.70e-04 | 67 | 23 | 3 | M26999 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 2.29e-04 | 14 | 23 | 2 | M22025 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.47e-04 | 76 | 23 | 3 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.06e-04 | 90 | 23 | 3 | M631 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 6.05e-04 | 439 | 23 | 5 | M42563 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 7.47e-04 | 25 | 23 | 2 | MM15546 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 8.08e-04 | 26 | 23 | 2 | M39407 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 8.08e-04 | 26 | 23 | 2 | MM14793 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.11e-04 | 114 | 23 | 3 | MM14571 | |
| Pathway | WP_MRNA_PROCESSING | 1.08e-03 | 126 | 23 | 3 | M39406 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.15e-03 | 31 | 23 | 2 | M39522 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 1.38e-03 | 34 | 23 | 2 | M27826 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.47e-03 | 140 | 23 | 3 | M587 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.64e-03 | 37 | 23 | 2 | M27797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 1.91e-03 | 40 | 23 | 2 | M47917 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.11e-03 | 42 | 23 | 2 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.11e-03 | 42 | 23 | 2 | M27272 | |
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 7.98e-07 | 20 | 32 | 3 | 11859196 | |
| Pubmed | Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. | 8.20e-07 | 2 | 32 | 2 | 8663425 | |
| Pubmed | Human class III POU genes, POU3F1 and POU3F3, map to chromosomes 1p34.1 and 3p14.2. | 8.20e-07 | 2 | 32 | 2 | 9457692 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 3.02e-06 | 1021 | 32 | 8 | 26760575 | |
| Pubmed | 4.06e-06 | 263 | 32 | 5 | 20932939 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 26334913 | ||
| Pubmed | Structure and evolution of four POU domain genes expressed in mouse brain. | 4.92e-06 | 4 | 32 | 2 | 1565620 | |
| Pubmed | Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells. | 4.92e-06 | 4 | 32 | 2 | 26265007 | |
| Pubmed | Polycomb complexes repress developmental regulators in murine embryonic stem cells. | 4.92e-06 | 4 | 32 | 2 | 16625203 | |
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 6.32e-06 | 39 | 32 | 3 | 34921112 | |
| Pubmed | 7.93e-06 | 42 | 32 | 3 | 23863479 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 9105675 | ||
| Pubmed | Cooperative function of POU proteins and SOX proteins in glial cells. | 8.19e-06 | 5 | 32 | 2 | 9632656 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 24419084 | ||
| Pubmed | Expression of a large family of POU-domain regulatory genes in mammalian brain development. | 1.23e-05 | 6 | 32 | 2 | 2739723 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 21399610 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 15713637 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 17301088 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 15975576 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.80e-05 | 358 | 32 | 5 | 32460013 | |
| Pubmed | 2.71e-05 | 63 | 32 | 3 | 22923088 | ||
| Pubmed | 2.72e-05 | 660 | 32 | 6 | 32780723 | ||
| Pubmed | 2.81e-05 | 191 | 32 | 4 | 24146773 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 15872005 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 11091071 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 16687444 | ||
| Pubmed | 3.70e-05 | 1442 | 32 | 8 | 35575683 | ||
| Pubmed | 3.77e-05 | 206 | 32 | 4 | 22174317 | ||
| Pubmed | 4.18e-05 | 713 | 32 | 6 | 29802200 | ||
| Pubmed | 4.82e-05 | 1497 | 32 | 8 | 31527615 | ||
| Pubmed | 4.88e-05 | 220 | 32 | 4 | 24550385 | ||
| Pubmed | Murine chromosomal location of four class III POU transcription factors. | 5.38e-05 | 12 | 32 | 2 | 8276397 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 35132438 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 15525528 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 5.38e-05 | 12 | 32 | 2 | 10631168 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 9247261 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 5.76e-05 | 457 | 32 | 5 | 32344865 | |
| Pubmed | 6.18e-05 | 83 | 32 | 3 | 28794006 | ||
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 8543156 | ||
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 30952667 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 7.11e-05 | 1155 | 32 | 7 | 20360068 | |
| Pubmed | Genetic control of dorsal-ventral identity in the telencephalon: opposing roles for Pax6 and Gsh2. | 7.41e-05 | 14 | 32 | 2 | 11003836 | |
| Pubmed | FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. | 7.41e-05 | 14 | 32 | 2 | 12571102 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 17141158 | ||
| Pubmed | Requirement for Twist1 in frontonasal and skull vault development in the mouse embryo. | 7.41e-05 | 14 | 32 | 2 | 19414008 | |
| Pubmed | Roles of Bmp4 during tooth morphogenesis and sequential tooth formation. | 7.41e-05 | 14 | 32 | 2 | 23250216 | |
| Pubmed | R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. | 8.55e-05 | 15 | 32 | 2 | 18256198 | |
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 10098408 | ||
| Pubmed | Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. | 8.55e-05 | 15 | 32 | 2 | 18255031 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 9118797 | ||
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 9.76e-05 | 16 | 32 | 2 | 9799237 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 19527706 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 19890917 | ||
| Pubmed | Strabismus regulates asymmetric cell divisions and cell fate determination in the mouse brain. | 9.76e-05 | 16 | 32 | 2 | 19332887 | |
| Pubmed | Smad4 controls proliferation of interstitial cells in the neonatal kidney. | 1.11e-04 | 17 | 32 | 2 | 34878095 | |
| Pubmed | MOZ directs the distal-less homeobox gene expression program during craniofacial development. | 1.11e-04 | 17 | 32 | 2 | 31340933 | |
| Pubmed | 1.14e-04 | 274 | 32 | 4 | 34244482 | ||
| Pubmed | Negative regulation of endothelin signaling by SIX1 is required for proper maxillary development. | 1.24e-04 | 18 | 32 | 2 | 28455376 | |
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 9716414 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.29e-04 | 283 | 32 | 4 | 28533407 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 10393115 | ||
| Pubmed | LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. | 1.39e-04 | 19 | 32 | 2 | 11165475 | |
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 1.39e-04 | 19 | 32 | 2 | 27122169 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.44e-04 | 1294 | 32 | 7 | 30804502 | |
| Pubmed | 1.51e-04 | 295 | 32 | 4 | 26209609 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 16221724 | ||
| Pubmed | Multiple requirements of the focal dermal hypoplasia gene porcupine during ocular morphogenesis. | 1.54e-04 | 20 | 32 | 2 | 25451153 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.58e-04 | 908 | 32 | 6 | 19274049 | |
| Pubmed | PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos. | 1.70e-04 | 21 | 32 | 2 | 18311137 | |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 1.87e-04 | 22 | 32 | 2 | 29449451 | |
| Pubmed | The cortical hem regulates the size and patterning of neocortex. | 1.87e-04 | 22 | 32 | 2 | 24948604 | |
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 20089898 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 17644613 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 28031177 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.05e-04 | 23 | 32 | 2 | 30962207 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.06e-04 | 954 | 32 | 6 | 36373674 | |
| Pubmed | 2.08e-04 | 125 | 32 | 3 | 29467281 | ||
| Pubmed | 2.17e-04 | 963 | 32 | 6 | 28671696 | ||
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 18697905 | ||
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 27507811 | ||
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 30084950 | ||
| Pubmed | Patterning the dorsal telencephalon: a role for sonic hedgehog? | 2.43e-04 | 25 | 32 | 2 | 17959802 | |
| Pubmed | Presenilin 1 in migration and morphogenesis in the central nervous system. | 2.43e-04 | 25 | 32 | 2 | 15163631 | |
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 26621269 | ||
| Pubmed | 2.56e-04 | 134 | 32 | 3 | 19030180 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 22992956 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 14960276 | ||
| Pubmed | 3.02e-04 | 652 | 32 | 5 | 31180492 | ||
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 30037996 | ||
| Pubmed | Emx1 and Emx2 cooperate in initial phase of archipallium development. | 3.05e-04 | 28 | 32 | 2 | 15147765 | |
| Pubmed | 3.28e-04 | 29 | 32 | 2 | 19279220 | ||
| Pubmed | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. | 3.28e-04 | 29 | 32 | 2 | 17928865 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.42e-04 | 148 | 32 | 3 | 32538781 | |
| Pubmed | 3.51e-04 | 30 | 32 | 2 | 19409883 | ||
| Pubmed | 3.51e-04 | 30 | 32 | 2 | 37158107 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 3.51e-04 | 30 | 32 | 2 | 15782174 | |
| Pubmed | 3.70e-04 | 152 | 32 | 3 | 38360978 | ||
| Pubmed | Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT). | 3.75e-04 | 31 | 32 | 2 | 29459093 | |
| Pubmed | 3.77e-04 | 153 | 32 | 3 | 25037231 | ||
| Pubmed | 4.00e-04 | 32 | 32 | 2 | 24706805 | ||
| Interaction | EWSR1 interactions | 7.94e-06 | 906 | 32 | 9 | int:EWSR1 | |
| Interaction | WBP4 interactions | 2.59e-05 | 109 | 32 | 4 | int:WBP4 | |
| Interaction | POU3F4 interactions | 3.65e-05 | 6 | 32 | 2 | int:POU3F4 | |
| Interaction | NUP35 interactions | 4.77e-05 | 424 | 32 | 6 | int:NUP35 | |
| Interaction | SNRNP40 interactions | 5.15e-05 | 637 | 32 | 7 | int:SNRNP40 | |
| Interaction | THRAP3 interactions | 6.08e-05 | 443 | 32 | 6 | int:THRAP3 | |
| Interaction | YPEL1 interactions | 6.80e-05 | 8 | 32 | 2 | int:YPEL1 | |
| Interaction | SNU13 interactions | 8.04e-05 | 285 | 32 | 5 | int:SNU13 | |
| Interaction | ADAR interactions | 8.18e-05 | 286 | 32 | 5 | int:ADAR | |
| Interaction | MOB4 interactions | 9.01e-05 | 150 | 32 | 4 | int:MOB4 | |
| Interaction | DDB1 interactions | 9.08e-05 | 697 | 32 | 7 | int:DDB1 | |
| Interaction | ACIN1 interactions | 1.04e-04 | 301 | 32 | 5 | int:ACIN1 | |
| Interaction | FLI1 interactions | 1.29e-04 | 62 | 32 | 3 | int:FLI1 | |
| Interaction | SART1 interactions | 1.33e-04 | 317 | 32 | 5 | int:SART1 | |
| Interaction | CTNNB1 interactions | 1.38e-04 | 1009 | 32 | 8 | int:CTNNB1 | |
| Interaction | GLDC interactions | 1.41e-04 | 321 | 32 | 5 | int:GLDC | |
| Interaction | SF3B2 interactions | 1.42e-04 | 517 | 32 | 6 | int:SF3B2 | |
| Interaction | SSU72 interactions | 1.55e-04 | 66 | 32 | 3 | int:SSU72 | |
| Interaction | RBM39 interactions | 1.72e-04 | 1042 | 32 | 8 | int:RBM39 | |
| Interaction | SF3B4 interactions | 1.89e-04 | 342 | 32 | 5 | int:SF3B4 | |
| Interaction | SRRM1 interactions | 2.05e-04 | 348 | 32 | 5 | int:SRRM1 | |
| Interaction | RBM14 interactions | 2.05e-04 | 553 | 32 | 6 | int:RBM14 | |
| Interaction | SMARCC2 interactions | 2.19e-04 | 353 | 32 | 5 | int:SMARCC2 | |
| Interaction | DDX5 interactions | 2.37e-04 | 568 | 32 | 6 | int:DDX5 | |
| Interaction | SF3B1 interactions | 2.44e-04 | 571 | 32 | 6 | int:SF3B1 | |
| Interaction | SMARCC1 interactions | 3.23e-04 | 384 | 32 | 5 | int:SMARCC1 | |
| Interaction | PRRC2A interactions | 3.42e-04 | 389 | 32 | 5 | int:PRRC2A | |
| Interaction | SS18 interactions | 3.64e-04 | 88 | 32 | 3 | int:SS18 | |
| Interaction | MIR92A2 interactions | 3.89e-04 | 90 | 32 | 3 | int:MIR92A2 | |
| Interaction | POU3F1 interactions | 4.11e-04 | 19 | 32 | 2 | int:POU3F1 | |
| Interaction | SOX10 interactions | 4.15e-04 | 92 | 32 | 3 | int:SOX10 | |
| Interaction | GATA4 interactions | 4.40e-04 | 411 | 32 | 5 | int:GATA4 | |
| Interaction | OBSL1 interactions | 4.43e-04 | 902 | 32 | 7 | int:OBSL1 | |
| Interaction | POU3F2 interactions | 4.56e-04 | 20 | 32 | 2 | int:POU3F2 | |
| Interaction | ALYREF interactions | 4.65e-04 | 416 | 32 | 5 | int:ALYREF | |
| Interaction | MIR19A interactions | 5.30e-04 | 100 | 32 | 3 | int:MIR19A | |
| Interaction | DHX9 interactions | 5.36e-04 | 662 | 32 | 6 | int:DHX9 | |
| Interaction | POU3F3 interactions | 5.53e-04 | 22 | 32 | 2 | int:POU3F3 | |
| Interaction | NUPR1 interactions | 6.32e-04 | 683 | 32 | 6 | int:NUPR1 | |
| Interaction | PRPF19 interactions | 6.65e-04 | 450 | 32 | 5 | int:PRPF19 | |
| Interaction | PCF11 interactions | 7.18e-04 | 111 | 32 | 3 | int:PCF11 | |
| Interaction | SNRNP200 interactions | 7.34e-04 | 460 | 32 | 5 | int:SNRNP200 | |
| Interaction | SNRNP70 interactions | 7.45e-04 | 984 | 32 | 7 | int:SNRNP70 | |
| Interaction | SMARCA4 interactions | 7.48e-04 | 462 | 32 | 5 | int:SMARCA4 | |
| Interaction | COL4A6 interactions | 7.75e-04 | 26 | 32 | 2 | int:COL4A6 | |
| Interaction | SMC5 interactions | 8.20e-04 | 1000 | 32 | 7 | int:SMC5 | |
| Interaction | DDX21 interactions | 8.22e-04 | 718 | 32 | 6 | int:DDX21 | |
| Interaction | SIPA1L3 interactions | 8.57e-04 | 118 | 32 | 3 | int:SIPA1L3 | |
| Interaction | GIPC1 interactions | 8.79e-04 | 119 | 32 | 3 | int:GIPC1 | |
| Interaction | DDX23 interactions | 8.89e-04 | 480 | 32 | 5 | int:DDX23 | |
| Interaction | DDIT3 interactions | 9.00e-04 | 120 | 32 | 3 | int:DDIT3 | |
| Interaction | SNRPA interactions | 9.05e-04 | 482 | 32 | 5 | int:SNRPA | |
| Cytoband | 18q21.33 | 5.61e-05 | 16 | 32 | 2 | 18q21.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 1.12e-03 | 294 | 32 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q25 | 1.85e-03 | 91 | 32 | 2 | chr4q25 | |
| GeneFamily | Collagens | 3.41e-05 | 46 | 25 | 3 | 490 | |
| GeneFamily | RNA binding motif containing | 1.95e-04 | 213 | 25 | 4 | 725 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.56e-04 | 23 | 25 | 2 | 523 | |
| GeneFamily | PDZ domain containing | 1.86e-02 | 152 | 25 | 2 | 1220 | |
| Coexpression | NABA_COLLAGENS | 1.97e-05 | 43 | 32 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.12e-05 | 44 | 32 | 3 | M3005 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.99e-05 | 261 | 30 | 5 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 4.83e-05 | 983 | 30 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | 8.47e-05 | 779 | 30 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.56e-05 | 532 | 30 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.31e-04 | 186 | 30 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_200 | 1.74e-04 | 14 | 30 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.11e-04 | 395 | 30 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 2.53e-04 | 411 | 30 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 2.56e-04 | 412 | 30 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.22e-04 | 433 | 30 | 5 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.23e-04 | 95 | 30 | 3 | gudmap_developingKidney_e11.5_ureteric bud_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 3.45e-04 | 978 | 30 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_100 | 3.64e-04 | 99 | 30 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 3.75e-04 | 100 | 30 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 5.26e-04 | 482 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 5.31e-04 | 483 | 30 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 5.51e-04 | 487 | 30 | 5 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 5.78e-04 | 492 | 30 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 5.83e-04 | 493 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 5.99e-04 | 496 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.09e-04 | 118 | 30 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 6.10e-04 | 498 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | 7.00e-04 | 786 | 30 | 6 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 7.33e-04 | 293 | 30 | 4 | PCBC_ratio_DE_from-ESC_vs_DE_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | 8.14e-04 | 809 | 30 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | 8.35e-04 | 813 | 30 | 6 | gudmap_developingKidney_e11.5_ureteric bud_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_1000 | 8.35e-04 | 813 | 30 | 6 | gudmap_developingKidney_e12.5_renal vesicle_1000 | |
| CoexpressionAtlas | DE blastocyst_vs_DE UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 8.73e-04 | 307 | 30 | 4 | PCBC_ratio_DE blastocyst_vs_DE UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 1.11e-03 | 145 | 30 | 3 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.15e-03 | 331 | 30 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 1.17e-03 | 148 | 30 | 3 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.29e-06 | 186 | 32 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.29e-06 | 186 | 32 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-06 | 188 | 32 | 4 | 459e3fd4335a6f25f982d011b38702f4fcfed1cd | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.69e-06 | 188 | 32 | 4 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-06 | 188 | 32 | 4 | 9fd262bbf6cdebfd945e39428a6059726fb55b3a | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.16e-05 | 197 | 32 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-05 | 198 | 32 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-05 | 198 | 32 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.21e-05 | 199 | 32 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 153 | 32 | 3 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-04 | 159 | 32 | 3 | 916d070d099726f22deb71966efccff00f8ea071 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-04 | 159 | 32 | 3 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 159 | 32 | 3 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-04 | 159 | 32 | 3 | 6599707107083af6da092fe8984afc8fd89d2bb8 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-04 | 163 | 32 | 3 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 164 | 32 | 3 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 2.22e-04 | 165 | 32 | 3 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 167 | 32 | 3 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | mild_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 2.30e-04 | 167 | 32 | 3 | 69330689b6e353c8ee9ea1b63a5eac6ab38d456f | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 168 | 32 | 3 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-04 | 170 | 32 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-04 | 170 | 32 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | mild_COVID-19-Treg|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.51e-04 | 172 | 32 | 3 | 77af6324c06b67867e7ce07706536fe38de5ed7b | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.51e-04 | 172 | 32 | 3 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.51e-04 | 172 | 32 | 3 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | critical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-04 | 173 | 32 | 3 | 4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 174 | 32 | 3 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-04 | 174 | 32 | 3 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.69e-04 | 176 | 32 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 177 | 32 | 3 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 177 | 32 | 3 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.73e-04 | 177 | 32 | 3 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | 6f3b254e56e722cc23495b49e99a4abce0243cb3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 179 | 32 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-04 | 180 | 32 | 3 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.91e-04 | 181 | 32 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 183 | 32 | 3 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 184 | 32 | 3 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 185 | 32 | 3 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 186 | 32 | 3 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | 76535681667c8afb884fa72b6edfee9e1e46335b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 187 | 32 | 3 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 187 | 32 | 3 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.26e-04 | 188 | 32 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 191 | 32 | 3 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 192 | 32 | 3 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.46e-04 | 192 | 32 | 3 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-04 | 192 | 32 | 3 | 9e031bf93eb8757fdd0cc22f01b44e48f85532d5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-04 | 192 | 32 | 3 | 3d777d07878269b87ec7e1f06489cae7c989d633 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.52e-04 | 193 | 32 | 3 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.52e-04 | 193 | 32 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 194 | 32 | 3 | 5bd0f739aa75f387cca7c3b2686493ee2d1ee968 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.57e-04 | 194 | 32 | 3 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.62e-04 | 195 | 32 | 3 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.68e-04 | 196 | 32 | 3 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.68e-04 | 196 | 32 | 3 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.68e-04 | 196 | 32 | 3 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.73e-04 | 197 | 32 | 3 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.79e-04 | 198 | 32 | 3 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-04 | 199 | 32 | 3 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-04 | 199 | 32 | 3 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 3.85e-04 | 199 | 32 | 3 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-04 | 200 | 32 | 3 | 553e9612874480f4d2a45671462e266cd0a09321 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.90e-04 | 200 | 32 | 3 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-04 | 200 | 32 | 3 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Neighborhood of DEK | 2.13e-04 | 58 | 22 | 3 | GNF2_DEK | |
| Drug | strontium ranelate | 4.05e-06 | 77 | 32 | 4 | CID006918182 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.95e-06 | 193 | 32 | 5 | 4406_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.49e-06 | 196 | 32 | 5 | 4419_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; HL60; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 3007_DN | |
| Drug | ticlopidine | 1.29e-05 | 103 | 32 | 4 | CID000005472 | |
| Drug | GK-101 | 1.74e-05 | 36 | 32 | 3 | CID000161853 | |
| Drug | Madecassol | 3.67e-05 | 46 | 32 | 3 | CID000108062 | |
| Drug | PCR 4099 | 4.19e-05 | 139 | 32 | 4 | CID000002806 | |
| Drug | d-indobufen | 4.73e-05 | 50 | 32 | 3 | CID000044562 | |
| Drug | ridogrel | 5.32e-05 | 52 | 32 | 3 | CID005362391 | |
| Drug | NSC49633 | 5.63e-05 | 53 | 32 | 3 | CID000023340 | |
| Drug | AC1LAKND | 9.01e-05 | 62 | 32 | 3 | CID000470146 | |
| Drug | cerous chloride | 1.07e-04 | 177 | 32 | 4 | ctd:C026690 | |
| Drug | BAPN | 1.35e-04 | 71 | 32 | 3 | CID000001647 | |
| Drug | malotilate | 1.35e-04 | 71 | 32 | 3 | CID000004006 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 1.41e-04 | 190 | 32 | 4 | 6199_UP | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 191 | 32 | 4 | 941_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 192 | 32 | 4 | 7176_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 192 | 32 | 4 | 2865_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 4566_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 3864_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 3206_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4970_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 2355_UP | |
| Drug | AC1NMZ1B | 1.59e-04 | 75 | 32 | 3 | CID005034185 | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2564_UP | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 7335_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 6867_UP | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2967_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 5332_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2038_UP | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.62e-04 | 197 | 32 | 4 | 825_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 7016_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 7182_DN | |
| Drug | halofuginone lactate | 2.30e-04 | 85 | 32 | 3 | CID000062891 | |
| Disease | Global developmental delay | 3.32e-04 | 133 | 30 | 3 | C0557874 | |
| Disease | small cell lung carcinoma | 3.01e-03 | 80 | 30 | 2 | EFO_0000702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPLGPDGNMGLGFQG | 211 | Q14031 | |
| PGTPKGAGMAGPGGL | 131 | P19419 | |
| EPGPLGGGGSGGPQM | 31 | O14908 | |
| AAAPGPMLGGGGDGG | 51 | Q8NFD5 | |
| PMLGGGGDGGGGLNS | 56 | Q8NFD5 | |
| GLGGGPKSGFLGPMA | 1576 | Q5TGY3 | |
| GPGPGSLAPGGGMQA | 266 | P33240 | |
| PQRMAGGGGPGSGGS | 246 | Q07687 | |
| MAGAGPAPGLPGAGG | 1 | Q9BTD8 | |
| MPQLSGGGGGGGGDP | 1 | Q9UJU2 | |
| GMGAPGVPGAAGVGG | 146 | Q9P260 | |
| GLGMGFGGSPGGGSL | 96 | Q99456 | |
| KPDGPGGGPGGSHMG | 451 | P35637 | |
| KGGIGLPGLPGANGM | 496 | Q9BXS0 | |
| MPSSLGQPDGGGGGG | 1 | Q86XN8 | |
| GLAGMLAAGGGGAGP | 171 | Q03052 | |
| MGLGGNPYGPAGTGK | 1681 | Q8NCM8 | |
| LPGPGGSMGLKNGAG | 76 | O00512 | |
| NGPSGGQGSFPGGMG | 1156 | O00512 | |
| GMGKPGLHGQPGPAG | 101 | P25067 | |
| NGMLSAPPGPGGGGG | 231 | P20264 | |
| GGGGGGPGMAAPPRQ | 6 | Q13033 | |
| GAGGGPGMGLSLGLG | 11 | Q8NC44 | |
| MQDAAAGGPPGLGGG | 1 | P0DH78 | |
| PGPHLMGGGGGAKGD | 246 | O60292 | |
| AAGAGMPGGGGGPSA | 76 | Q9C0B9 | |
| GGQGPRGMGPGTPAG | 676 | P23246 | |
| GGPGGGTGVPDGMGQ | 2051 | Q9C0A1 | |
| GGNGGGKPPSGPNRM | 56 | Q8N3U4 | |
| GGLGGKMNSGPPGLG | 336 | Q15050 | |
| MAPQKHGGGGGGGSG | 1 | Q15022 | |
| MGPLQGDGGPALGGA | 1 | Q9H1D0 | |
| SGNSIPGSMGPGGGG | 271 | P78364 | |
| GGGGPGMGPIGVKKH | 761 | P23378 |